|  Help  |  About  |  Contact Us

Publication : KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria.

First Author  Hortle E Year  2019
Journal  Sci Rep Volume  9
Issue  1 Pages  6356
PubMed ID  31015511 Mgi Jnum  J:280817
Mgi Id  MGI:6357239 Doi  10.1038/s41598-019-42782-x
Citation  Hortle E, et al. (2019) KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria. Sci Rep 9(1):6356
abstractText  Plasmodium falciparum malaria causes half a million deaths per year, with up to 9% of this mortality caused by cerebral malaria (CM). One of the major processes contributing to the development of CM is an excess of host inflammatory cytokines. Recently K+ signaling has emerged as an important mediator of the inflammatory response to infection; we therefore investigated whether mice carrying an ENU induced activation of the electroneutral K+ channel KCC1 had an altered response to Plasmodium berghei. Here we show that Kcc1(M935K/M935K) mice are protected from the development of experimental cerebral malaria, and that this protection is associated with an increased CD4+ and TNFa response. This is the first description of a K+ channel affecting the development of experimental cerebral malaria.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression